U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443176) titled 'FCI-Glioblastoma Study' on Feb. 05.
Brief Summary: The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can tell the difference between tumour growth (progression) and 'pseudo-progression' (which looks like tumour but is not cancerous tissue) in patients with glioblastoma. The main question it aims to answer is:
* Can FCI differentiate glioblastoma progression from pseudo-progression?
Participants will undergo a standard MRI scan and an FCI scan, three times during the study. One before starting adjuvant chemotherapy, another one after three cycles and one at the end of treatment.
St...